ClinicalTrials.Veeva

Find clinical trials for Eczema in Philadelphia, PA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Dermatitis
Atopic Dermatitis
Dyssomnias
Food Hypersensitivity
Hypersensitivity
Parasomnias
Psoriasis

Eczema trials near Philadelphia, PA, USA:

Open Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-OLE)

This study will assess the safety and efficacy of ARQ-151 cream applied once a day for 52 weeks by subjects with atopic dermatitis (eczema)....

Active, not recruiting
Atopic Dermatitis Eczema
Drug: ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%

Phase 3

Arcutis Biotherapeutics
Arcutis Biotherapeutics

Newtown Square, Pennsylvania, United States and 91 other locations

The study will assess the safety and efficacy of lebrikizumab in adult and adolescent participants with moderate-to-severe atopic dermatitis (AD) pre...

Active, not recruiting
Atopic Dermatitis
Drug: Lebrikizumab

Phase 3

Lilly
Lilly

Exton, Pennsylvania, United States and 41 other locations

The main purpose of this study is to determine the safety and efficacy lebrikizumab in adolescent and adult participants with moderate-to-severe atop...

Enrolling
Atopic Dermatitis
Drug: Lebrikizumab

Phase 3

Lilly
Lilly

Philadelphia, Pennsylvania, United States and 47 other locations

The purpose of this study is to learn about the safety and effects of 2 study medicines (PF-07275315 and PF-07264660) for the treatment of atopic der...

Enrolling
Atopic Dermatitis
Other: Placebo
Drug: PF-07264660

Phase 2

Pfizer
Pfizer

Philadelphia, Pennsylvania, United States and 40 other locations

This is a Phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of subcutaneous lirentelimab (...

Active, not recruiting
Atopic Dermatitis
Drug: AK002
Other: Placebo

Phase 2

Allakos

Philadelphia, Pennsylvania, United States and 54 other locations

The primary objective of this study is to evaluate the safety of IMG-007 in adults with moderate-to-severe AD. The secondary objectives are to evalua...

Active, not recruiting
Atopic Dermatitis
AD
Drug: IMG-007
Drug: Placebo

Phase 1, Phase 2

Inmagene

Philadelphia, Pennsylvania, United States and 11 other locations

The primary objective of the study is to assess the long-term safety of dupilumab in pediatric participants with AD.The secondary objectives of the s...

Active, not recruiting
Atopic Dermatitis
Drug: Dupilumab

Phase 3

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Philadelphia, Pennsylvania, United States and 83 other locations

The main purpose of this study is to measure the effect, safety and how well the body absorbs lebrikizumab in pediatric participants 6 months to <18...

Enrolling
Eczema
Atopic Dermatitis
Drug: Topical corticosteroid
Drug: Placebo

Phase 3

Lilly
Lilly

Exton, Pennsylvania, United States and 96 other locations

, compared with placebo in combination with TCS/TCI at Week 24, assessed using Eczema Area and Severity Index (EASI)....

Enrolling
Atopic Dermatitis
Other: Placebo
Drug: Rocatinlimab

Phase 3

Amgen
Amgen

Philadelphia, Pennsylvania, United States and 234 other locations

24 weeks open-label study with dupilumab and narrowband UVB phototherapy three times weekly for 12 weeks followed by 12 weeks of dupilumab monotherap...

Enrolling
Atopic Dermatitis
Drug: Dupixent

Phase 4

Psoriasis Treatment Center of Central New Jersey

East Windsor, New Jersey, United States

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems